background
passiv
transfer
antibodi
provid
immedi
shortterm
protect
diseas
also
exploit
therapeut
tool
howev
human
murin
monoclon
antibodi
mab
timeconsum
expens
process
inher
drawback
potenti
alter
antigen
specif
andor
affin
immort
human
b
cell
repres
altern
obtain
human
mab
reli
avail
biolog
sampl
vaccin
individu
convalesc
patient
work
describ
novel
approach
gener
fulli
human
mab
combin
human
mous
model
new
b
cell
immort
techniqu
methodologyprincip
find
transplant
human
hematopoiet
progenitor
cell
balbc
mice
acquir
human
immun
system
harbor
b
cell
divers
igm
repertoir
human
immun
system
mice
immun
two
commerci
vaccin
antigen
tetanu
toxoid
hepat
b
surfac
antigen
sort
human
b
cell
retrovir
transduc
human
b
cell
lymphoma
bcl
bclxl
gene
subsequ
cultur
presenc
procedur
allow
gener
stabl
b
cell
receptorposit
b
cell
secret
immunoglobulin
recov
stabl
b
cell
clone
produc
igm
specif
tetanu
toxoid
hepat
b
surfac
antigen
respect
conclusionsignific
work
provid
proofofconcept
use
novel
method
base
immun
human
mice
rapid
gener
human
mab
wide
rang
antigen
hyperimmun
sera
contain
polyclon
immunoglobulin
ig
wide
use
therapeut
prophylact
clinic
set
howev
use
polyclon
sera
associ
sever
problem
stimul
allerg
reaction
low
reproduc
clinic
batch
high
offlabel
use
final
caus
declin
use
advent
technolog
make
monoclon
antibodi
mab
deriv
anim
especi
mice
overcom
mani
problem
associ
use
polyclon
sera
technolog
make
monoclon
cell
line
antibodyproduc
cell
fuse
antibodi
produc
plasma
cell
myeloma
cell
describ
first
time
milstein
kohler
therapeut
potenti
mab
immedi
recogn
first
mab
approv
therapeut
applic
antibodi
inactiv
cell
therebi
prevent
reject
organ
transplant
howev
anim
origin
first
gener
mab
use
clinic
trial
human
subject
treat
antibodi
develop
vigor
immun
reaction
anim
protein
therebi
elimin
prevent
therapeut
action
overcom
problem
technolog
develop
diminish
immunogen
mous
antibodi
replac
part
complet
mous
antibodi
backbon
human
equival
first
gener
chimer
subsequ
fulli
human
antibodi
parallel
approach
transgen
mice
bear
human
ig
region
creat
obtain
fulli
human
antibodi
follow
immun
use
mice
obviat
elabor
molecular
engin
antibodi
need
human
antibodi
gener
wildtyp
mice
howev
matur
process
mous
b
cell
express
human
ig
differ
fulli
human
b
cell
immort
b
cell
immun
human
seem
logic
strategi
avoid
problem
howev
method
achiev
goal
show
low
effici
although
progress
recent
report
nevertheless
major
disadvantag
human
b
cell
immort
need
cell
either
vaccin
individu
patient
recov
infect
thu
fulli
exploit
ig
repertoir
human
b
cell
vivo
set
explor
possibl
rais
mab
follow
de
novo
induct
human
b
cell
respons
mice
carri
element
human
immun
system
mice
gener
engraft
immunodefici
mice
human
hematopoiet
stem
cell
hsc
without
human
lymphoid
tissu
fetal
origin
particular
mice
defici
recombinas
activ
common
gamma
chain
receptor
balbc
nonobes
diabet
nod
background
permiss
human
hsc
xenograft
inocul
newborn
mice
strain
human
hsc
fetal
umbil
cord
blood
origin
give
rise
robust
engraft
number
immun
cell
includ
b
nk
dendrit
cell
work
describ
conveni
approach
gener
fulli
human
mab
base
immun
balbc
engraft
human
hsc
end
mice
immun
commerci
vaccin
hepat
b
viru
hbv
tetanu
follow
immun
human
b
cell
sort
base
surfac
express
marker
memori
phenotyp
isotyp
surfac
ig
sort
b
cell
popul
immort
vitro
retrovir
transduct
human
b
cell
lymphoma
bcl
bclxl
gene
antigenspecif
b
cell
clone
establish
character
obtain
result
provid
proofofconcept
use
gener
approach
base
mice
combin
immort
human
b
cell
rapid
inexpens
develop
human
mab
wide
rang
antigen
use
fetal
liver
tissu
obtain
elect
abort
gestat
age
rang
week
approv
medic
ethic
committe
amcuva
conting
inform
written
consent
balbc
mice
bred
maintain
individu
ventil
cage
fed
autoclav
food
water
mice
gener
previous
describ
approv
anim
ethic
committe
amcuva
permit
number
brief
human
fetal
liver
obtain
elect
abort
gestat
age
rang
week
magnet
enrich
cell
pure
perform
use
progenitor
cell
isol
kit
miltenyi
biotech
prepar
singl
cell
suspens
isol
mononuclear
cell
densiti
gradient
centrifug
lymphoprep
axi
shield
final
newborn
day
old
subleth
irradi
gy
balbc
mice
inject
via
intrahepat
rout
sort
human
fetal
liver
hematopoiet
stem
cell
ml
manipul
mice
perform
laminar
flow
cell
suspens
prepar
rpmi
medium
supplement
fetal
calf
serum
fc
twelv
sixteen
week
hsc
engraft
mice
kill
singl
cell
suspens
splenocyt
prepar
red
cell
lysi
perform
ml
red
cell
lysi
buffer
sigma
min
splenocyt
wash
resuspend
ml
rlt
lysi
buffer
qiagen
homogen
pass
needl
sever
time
use
rnase
free
syring
rna
prepar
use
rneasi
mini
kit
qiagen
accord
manufactur
instruct
bcr
v
h
immunoscop
perform
previous
describ
briefli
cdna
prepar
realtim
pcr
perform
combin
primer
differ
v
h
chain
v
h
specif
fluorochromelabel
probe
differ
constant
region
c
h
c
h
c
h
c
addit
four
pcr
cycl
runoff
reaction
perform
pcr
product
use
fluoresc
primer
specif
constant
region
fcm
fca
fcc
product
gel
separ
determin
length
analysi
six
individu
hismic
contain
greater
human
chimer
spleen
perform
number
human
b
cell
chimer
spleen
rang
eight
week
hsc
transplant
blood
taken
mice
verifi
level
engraft
flow
cytometri
describ
elsewher
mice
good
level
human
reconstitut
cell
immun
intramuscular
rout
bicep
femori
use
needl
three
time
week
either
ml
hbv
vaccin
engerixb
glaxosmithklin
ml
tetanu
toxoid
tt
contain
vaccin
tetanu
vaccin
netherland
vaccin
institut
amount
correspond
normal
human
dose
neg
control
receiv
volum
pb
buffer
two
week
last
immun
mice
exsanguin
isofluranoxygen
narcosi
spleen
mln
remov
asept
cellular
suspens
prepar
bm
cell
isol
femur
tibia
beckman
coulter
igm
igd
igg
bd
bioscienc
abdserotec
ebiosci
ttspecif
b
cell
also
occasion
stain
pecoupl
tt
kindli
provid
dr
andrea
radbruch
german
rheumat
research
center
berlin
germani
dead
cell
exclud
base
dapi
incorpor
wash
reagent
dilut
done
pb
contain
fc
nan
stain
cell
analyz
lsrii
interfac
facsdiva
softwar
system
bd
bioscienc
cell
sort
b
cell
subset
perform
mous
bm
spleen
use
facsaria
cell
sorter
interfac
facsdiva
softwar
system
bd
bioscienc
experi
wash
reagent
dilut
done
fc
supplement
pb
without
nan
human
bclxl
encod
cdna
clone
lzr
retrovir
express
vector
around
cleavagepromot
peptid
sequenc
upstream
cassett
contain
intern
ribosom
entri
site
ire
gene
encod
gfp
therefor
obtain
lzr
vector
follow
configur
transfect
phoenixgalv
packag
cell
viru
product
perform
previous
describ
retrovir
transduct
memori
b
cell
activ
cirradi
gy
mous
l
cell
fibroblast
stabli
express
cell
presenc
ngml
recombin
mous
r
system
h
b
cell
wash
mix
retrovir
supernat
retronectinco
plate
takara
centrifug
room
temperatur
min
g
subsequ
incub
retrovirus
co
h
transduc
b
cell
maintain
cocultur
use
cell
cellsml
standard
imdm
gibco
cultur
medium
supplement
fetal
bovin
serum
fb
hyclon
penicillinstreptomycin
roch
ngml
analysi
human
igv
h
sequenc
perform
follow
total
rna
isol
approxim
monoclon
b
cell
trizol
invitrogen
cdna
gener
subject
pcr
primer
specif
differ
v
h
famili
member
pcr
product
sequenc
determin
region
differ
clone
sequenc
analysi
perform
use
bigdy
termin
chemistri
appli
biosystem
inc
codoncod
align
softwar
plasma
harvest
mice
day
first
second
immun
day
third
immun
b
cell
clone
cultur
supernat
screen
elisa
presenc
total
human
igm
total
human
igg
antigenspecif
antibodi
measur
total
igm
igg
perform
coat
plate
either
affinipur
f
ab
fragment
goat
antihuman
igm
jackson
immunoresearch
affinipur
goat
antihuman
igg
fcc
fragmentspecif
jackson
immunoresearch
control
human
serum
protein
calibr
dako
known
igm
mgml
igg
mgml
concentr
use
standard
compar
sampl
detect
antigenspecif
antibodi
plate
coat
either
tetanu
vaccin
nederland
vaccin
instituut
engerix
b
glaxosmithklin
dilut
pb
h
overnight
altern
ridascreen
tetanu
igg
elisa
plate
biopharm
also
use
screen
ttspecif
antibodi
coat
plate
wash
elisa
wash
buffer
pb
pb
solut
contain
milk
use
block
agent
ad
serial
dilut
mous
plasma
start
dilut
cell
cultur
supernat
start
dilut
enzymeconjug
detect
antibodi
ad
dilut
hrpconjug
antiigg
dilut
hrpconjug
antiigm
jackson
immunoresearch
tmb
substratestop
solut
biosourc
use
develop
elisa
assay
statist
analys
perform
use
graphpad
prism
version
window
graphpad
softwar
data
subject
twotail
unpair
student
test
analysi
obtain
p
valu
consid
signific
gener
mice
transplant
human
hsc
alymphoid
balbc
newborn
mice
figur
report
previous
multilineag
human
hematopoiet
reconstitut
observ
mice
demonstr
human
thymopoiesi
b
cell
differenti
nk
cell
plasmacytoid
dendrit
cell
develop
myelopoiesi
human
immun
cell
accumul
lymphoid
tissu
sever
b
cell
subset
observ
mice
figur
analyz
human
b
cell
repertoir
present
naiv
mice
use
b
cell
receptor
bcr
immunoscop
analysi
base
quantit
pcr
ig
variabl
v
h
constant
c
h
region
gene
segment
due
lack
human
spleen
sampl
cell
isol
mous
spleen
contain
suffici
number
human
b
cell
perform
immunoscop
analysi
compar
control
human
peripher
blood
mononuclear
cell
pbmc
sampl
consid
accept
purpos
perform
comparison
observ
igmexpress
b
cell
well
ig
isotypeswitch
b
cell
found
naiv
mice
figur
vast
major
b
cell
mice
express
igm
wherea
igg
iga
express
b
cell
repres
minor
popul
frequenc
igaexpress
b
cell
found
significantli
higher
control
human
pbmc
sampl
week
posttransplant
ie
steadi
state
condit
human
ig
concentr
blood
mgml
igm
mgml
igg
figur
previous
report
comparison
normal
rang
ig
concentr
healthi
human
mg
igmml
mg
iggml
brief
despit
low
frequenc
iggexpress
cell
human
igm
igg
accumul
plasma
monthold
mice
level
repres
around
adult
human
igm
igg
concentr
respect
examin
antigen
receptor
repertoir
divers
mice
determin
length
hypervari
region
igv
h
gene
famili
analysi
length
distribut
individu
mous
splenocyt
show
igm
repertoir
undistinguish
normal
human
pbmc
igm
repertoir
measur
bcr
immunoscop
analysi
figur
observ
suggest
mice
contain
broad
varieti
naiv
igm
b
cell
clone
v
h
famili
usag
larg
similar
control
human
pbmc
tabl
bcr
immunoscop
analysi
also
perform
igg
iga
repertoir
observ
restrict
repertoir
expect
b
cell
undergo
clonal
select
ig
class
switch
recombin
figur
immun
mice
hbv
tetanu
vaccin
result
gener
antigenspecif
antibodi
respons
sinc
mice
contain
broad
b
cell
repertoir
analyz
induct
human
antigenspecif
b
cell
respons
immun
commerci
avail
human
vaccin
design
vaccin
protocol
base
repeat
intramuscular
immun
inject
interv
old
mice
vaccin
contain
hepat
b
surfac
antigen
hbsag
tt
seven
day
last
immun
mice
sacrif
blood
lymphoid
organ
harvest
phenotyp
function
human
cell
analyz
mice
show
human
reconstitut
cell
blood
start
immun
protocol
correl
human
engraft
lymphoid
organ
overal
hbsagvaccin
vaccin
anim
ttvaccin
mice
show
signific
product
antigenspecif
igm
antibodi
detect
elisa
figur
perform
kinet
monitor
antigenspecif
plasma
ig
level
individu
hbsagvaccin
respond
mice
observ
first
immun
antigenspecif
ig
rare
detect
contrast
second
immun
antigenspecif
igm
detect
steadili
increas
third
immun
approxim
respond
mice
also
show
antigenspecif
igg
respons
figur
suggest
repeat
vaccin
lead
enhanc
antigenspecif
antibodi
product
respond
mice
exhibit
higher
total
igm
mgml
total
igg
mgml
concentr
plasma
compar
pbsinject
igm
mgml
igg
mgml
nonrespond
vaccin
igm
mgml
igg
mgml
anim
figur
end
immun
protocol
vaccin
anim
show
significantli
higher
number
cell
organ
ie
spleen
bone
marrow
bm
mesenter
lymph
node
mln
comparison
mockinject
control
mice
respond
mice
exhibit
higher
number
human
b
cell
spleen
well
cell
bm
tabl
tabl
suggest
vaccin
protocol
posit
impact
accumul
human
b
cell
moreov
mln
isol
vaccin
mice
contain
cell
control
anim
figur
suggest
mln
structur
might
play
role
elicit
immun
respons
mice
human
memori
b
cell
popul
contain
major
antigenexperienc
b
cell
reason
true
vaccin
mice
therefor
cell
sort
sever
differ
b
cell
subset
individu
mice
use
two
strategi
isol
follow
human
b
cell
subset
bm
spleen
vaccin
mice
hi
hi
ii
loint
igd
iii
loint
igd
one
hand
figur
although
number
cell
increas
subpopul
vaccin
anim
expect
enhanc
number
total
b
cell
tabl
observ
signific
increas
frequenc
igg
b
cell
within
hi
hi
plasmablast
popul
vaccin
respond
mice
compar
pbsinject
anim
hi
hi
b
cell
respect
p
order
identifi
isol
immort
antigenspecif
antibodyproduc
b
cell
aforement
b
cell
subset
transduc
immedi
cell
sort
retrovir
vector
encod
human
bclxl
ectop
express
bclxl
splenic
peripher
blood
memori
b
cell
cultur
factor
produc
follicular
helper
cell
gener
highli
prolif
bcr
posit
b
cell
line
secret
ig
sinc
cell
express
differenti
memori
b
cell
termin
plasma
cell
block
therefor
result
b
cell
expand
extens
vitro
long
period
time
presenc
provid
tool
gener
antigenspecif
human
bcrposit
antibodysecret
b
cell
line
number
isol
cell
spleen
antigenspecif
b
cell
clone
gener
transduct
approach
provid
tabl
sinc
frequenc
antigenspecif
b
cell
clone
unknown
start
microcel
cultur
rang
cell
per
well
well
contain
antigenspecif
b
cell
determin
hbsagspecif
ttspecif
elisa
subsequ
cultur
limit
dilut
obtain
monoclon
b
cell
line
overal
gener
antihbsag
igm
b
cell
clone
mice
vaccin
hbsag
antitt
igm
b
cell
clone
mice
vaccin
tt
tabl
estim
frequenc
hbsagspecif
b
cell
clone
mice
vaccin
igm
secret
level
b
cell
clone
rang
mg
per
cell
day
cultur
similar
rang
secret
day
previous
report
b
cell
clone
gener
human
blood
igm
v
h
region
bcr
antigenspecif
igm
b
cell
clone
sequenc
overal
bcr
hbsagspecif
ttspecif
b
cell
clone
exhibit
v
h
sequenc
close
germlin
sequenc
although
limit
frequenc
somat
hypermut
observ
tabl
tabl
somat
hypermut
occasion
detect
framework
region
fr
complementari
determin
region
cdr
bcr
divers
result
naddit
region
base
bcr
sequenc
observ
antihbsag
igm
b
cell
clone
uniqu
well
antitt
igm
b
cell
clone
tabl
tabl
tabl
supernat
ttspecif
b
cell
clone
test
capac
recogn
differ
antigen
elisa
observ
igm
mab
crossreact
unrel
antigen
ie
hbsag
respiratori
syncyti
viru
rsv
antigen
figur
ttspecif
b
cell
clone
also
screen
flow
cytometri
direct
bind
tt
antigen
label
fluorochrom
figur
interestingli
three
type
clone
produc
antibodi
gave
similar
signal
elisa
detect
high
intermedi
low
bind
fluoresc
tt
antigen
present
work
establish
new
approach
gener
fulli
human
mab
immort
b
cell
vaccin
mice
transduct
bclxl
follow
expans
presenc
antigenspecif
b
cell
clone
obtain
express
bcr
cell
surfac
secret
antigenspecif
antibodi
similarli
method
base
immort
human
memori
b
cell
individu
either
vaccin
expos
pathogen
strategi
exploit
antibodi
repertoir
human
b
cell
like
differ
b
cell
mice
express
human
ig
gene
segment
mice
display
extens
human
igmexpress
b
cell
repertoir
base
analysi
length
region
igm
b
cell
repertoir
similar
repertoir
healthi
individu
thu
mice
obviou
limit
gener
human
igm
mab
possibl
antigen
upon
intramuscular
vaccin
either
tt
hbsag
approxim
mice
abl
mount
antigenspecif
antibodi
respons
human
igmproduc
b
cell
line
antigen
obtain
isol
memori
b
cell
follow
ex
vivo
differenti
plasmablastlik
cell
import
highlight
select
antigenspecif
human
b
cell
clone
reli
relev
bioassay
eg
elisa
neutral
test
contrast
ebvbas
approach
human
b
cell
immort
use
transduct
bclxl
preserv
express
bcr
surfac
antigenspecif
b
cell
clone
also
select
bind
label
antigen
bcr
immort
memori
b
cell
eg
use
label
antigen
even
igg
use
select
criterion
unabl
establish
antigenspecif
igg
human
b
cell
clone
reason
might
cell
help
system
suboptim
indic
absenc
antigenspecif
cell
respons
vaccin
shown
also
observ
bcr
b
cell
clone
close
germlin
sequenc
suggest
also
induct
somat
hypermut
suboptim
mice
hand
great
major
vaccin
mice
show
defect
format
germin
center
explain
absenc
antigenspecif
igclass
switch
b
cell
far
human
mous
model
base
transplant
human
hsc
ie
without
addit
human
tissu
share
limit
immun
strategi
result
limit
gener
classswitch
antigenspecif
b
cell
respons
similar
pattern
observ
human
hsctransplant
immunodefici
mice
infect
lymphotrop
pathogen
hiv
ebv
although
dengu
viru
infect
mice
report
induc
igg
respons
major
respond
anim
clear
igg
antigenspecif
respons
limit
serum
igg
accumul
effici
consid
low
frequenc
igg
b
cell
mice
remain
determin
whether
appar
discrep
might
explain
conjunct
particularli
effect
igg
product
cell
basi
igg
b
cell
might
occur
cell
independ
manner
case
subclass
longterm
stabil
human
igg
mous
serum
compar
human
igm
andor
defect
surviv
igg
b
cell
specif
condit
eg
antigenspecif
trigger
bcr
although
igm
mab
might
alreadi
use
specif
applic
could
modifi
ig
class
swap
obtain
igg
mab
optim
human
mous
model
improv
b
cell
function
highli
desir
one
reason
suboptim
interact
b
cell
may
poor
surviv
result
high
turnov
human
cell
discuss
make
like
procedur
lead
improv
accumul
human
cell
may
promot
b
cell
respons
isotyp
switch
alreadi
shown
human
b
cell
undergo
isotyp
switch
obtain
human
mice
provid
human
environ
support
process
present
eg
scid
mice
transplant
human
fetal
bone
thymu
lymph
node
consist
notion
enhanc
human
peripher
cell
accumul
observ
nodscid
mice
transplant
human
bone
marrow
hsc
fetal
liver
fetal
thymu
tissu
refer
blt
mice
compar
convent
human
mous
system
interestingli
blt
mice
consist
gener
antigenspecif
igg
respons
hivinfect
although
yet
unknown
whether
isotyp
switch
observ
blt
mice
truli
cell
depend
data
might
support
idea
improv
cell
homeostasi
posit
impact
b
cell
respons
obtain
human
mous
model
improv
b
cell
homeostasi
altern
strategi
reli
transplant
human
fetal
tissu
necessarili
easi
access
ethic
legal
practic
reason
like
favor
futur
replac
mous
gene
involv
hematopoiet
system
human
equival
valuabl
strategi
improv
develop
mainten
andor
function
sever
hematopoiet
cell
subset
human
mous
model
shown
cytokin
mhc
molecul
ndh
jpd
manuscript
submit
fact
human
shown
unabl
properli
interact
mous
sirpa
indic
reintroduc
function
phagocyt
inhibit
mechan
via
signal
axi
anoth
strategi
potenti
interest
conclus
result
show
use
two
standard
vaccin
antigen
gener
applic
innov
b
cell
immort
method
combin
mous
model
gener
human
mab
similarli
method
base
immort
human
memori
b
cell
vaccin
convalesc
individu
approach
exploit
broad
antibodi
repertoir
human
b
cell
overcom
potenti
limit
convent
human
murin
mab
labori
impair
biolog
properti
synthet
antibodi
librari
requir
known
target
antigen
transgen
mice
bear
human
ig
locu
limit
b
cell
repertoir
addit
method
enabl
exploit
experiment
infect
model
immun
regim
would
uneth
unten
human
consid
upcom
advanc
mice
model
new
approach
provid
power
tool
gener
human
mab
either
diagnost
therapeut
purpos
figur
iggiga
b
cell
repertoir
mice
similarli
figur
naiv
igg
iga
b
b
cell
repertoir
balbragc
mice
evalu
splenocyt
perform
bcr
immunoscop
v
h
famili
profil
obtain
control
human
pbmc
also
shown
found
mb
tif
figur
limit
dilut
b
cell
transduc
bclxl
perform
cellswel
subclon
posit
well
gener
igm
antihbsag
mab
uniqu
determin
igv
h
sequenc
see
tabl
igm
antitt
mab
uniqu
see
tabl
case
hbsag
vaccin
number
screen
b
cell
eventu
suggest
frequenc
hbsagspecif
b
cell
least
b
cell
found
mb
doc
igm
v
h
aminoacid
sequenc
gener
hbsagspecif
b
cell
clone
germlin
sequenc
given
v
h
famili
indic
framework
region
fr
complementari
determin
region
cdr
highlight
aminoacid
correspond
naddit
region
somat
hypermut
event
whether
result
silent
mutat
green
red
clone
ident
bcr
sequenc
group
togeth
found
mb
pdf
